Ptpn6

Summary

Gene Symbol: Ptpn6
Description: protein tyrosine phosphatase, non-receptor type 6
Alias: Hcph, Ptp1C, SHP-1, hcp, motheaten, 70Z-SHP, PTP-1C, PTPTY-42, SH-PTP1, hematopoietic cell protein-tyrosine phosphatase, hemopoietic cell phosphatase, protein-tyrosine phosphatase 1C, tyrosine-protein phosphatase non-receptor type 6
Species: mouse

Top Publications

  1. ncbi Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice
    V Lipsanen
    Department of Pathobiology, University of Guelph, Ontario, Canada
    Int Immunol 9:655-64. 1997
  2. ncbi The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate
    K L Berg
    Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA
    Oncogene 17:2535-41. 1998
  3. ncbi The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells
    J Zhang
    Department of Immunology, University of Toronto, The Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Ontario, Canada
    J Immunol 162:6359-67. 1999
  4. ncbi Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice
    Melissa J Joliat
    The Jackson Laboratory, Bar Harbor, ME 04609, USA
    J Autoimmun 18:105-17. 2002
  5. ncbi SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC
    Anita M Kant
    Herman B Wells Center for Pediatrics Research, Indiana University School of Medicine, Indianapolis 46202, USA
    Blood 100:1852-9. 2002
  6. ncbi Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13
    T L Yi
    Department of Biochemistry, St Jude Children s Research Hospital, Memphis, Tennessee 38105
    Mol Cell Biol 12:836-46. 1992
  7. ncbi The interaction of the xid and me genes
    C L Scribner
    J Immunol 138:3611-7. 1987
  8. ncbi High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages
    A Veillette
    McGill Cancer Centre, McGill University, Montreal, Quebec, Canada H3G 1Y6
    J Biol Chem 273:22719-28. 1998
  9. ncbi Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1
    R F Paulson
    Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
    Nat Genet 13:309-15. 1996
  10. ncbi Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
    L D Shultz
    Jackson Laboratory, Bar Harbor, Maine 04609
    Cell 73:1445-54. 1993

Scientific Experts

  • Dae Joon Kim
  • Per Arne Oldenborg
  • Alison Taylor
  • Lily I Pao
  • Jack L Strominger
  • Bonnie L Lyons
  • A D Farris
  • T Kurosaki
  • A Horvat
  • S Q Liu
  • Shin ichi Hayashi
  • BRUCE A BEUTLER
  • Leonard D Shultz
  • Melanie J Welham
  • PAUL MASSA
  • Ben A Croker
  • K A Siminovitch
  • Sun Young Oh
  • Caishu Deng
  • Taichang Yuan
  • Li Zhang
  • Tessy Iype
  • Tomoko Isosaka
  • Zhou Zhu
  • Tao Zheng
  • W Yang
  • Jacqueline Reinhard
  • Wenbin Xiao
  • Alexander Nyström
  • Hyun Ju Kim
  • George P Christophi
  • Bitao Liang
  • Sihoon Lee
  • T Yi
  • Kazuko Nakata
  • J Zhang
  • Mélanie Simoneau
  • Jean G Sathish
  • Jason K Kim
  • Fabiano Pinheiro da Silva
  • Celine A Beamer
  • Toshiaki Kawakami
  • Marie Julie Dubois
  • Hiroyuki Nishimura
  • Yuko Kawakami
  • Diana I Lurie
  • Il Kyoo Park
  • Zan Huang
  • Christoph Biskup
  • Guo Wei
  • Jie Zhao
  • Kentaro T Hara
  • Zhiyuan Zhang
  • Hidetoshi Kumagai
  • Dong Hui Chung
  • Amy E Lovett-Racke
  • Rehana Z Hussain
  • Michael K Racke
  • Melissa J Joliat
  • Nicholas R D Paling
  • Yoon Kwang Lee
  • Taolin Yi
  • Anita M Kant
  • M Tabrizi
  • G Forget
  • C A Wishcamper
  • H Jiao
  • Yongping Wang
  • Steve M Anderson
  • Haihua Gu
  • Ileana S Mauldin
  • Min Hee Oh
  • B Lowin-Kropf
  • David W Mullins
  • Clifford M Takemoto
  • Shigeki Yuasa
  • Ulrike Lorenz
  • Xinxing Wu
  • Mohan Sankarshanan
  • J Kruger
  • Fan Wu
  • John T Schroeder
  • Hiromitsu Nakauchi
  • Cyrus C Hsia
  • Donald Gullberg
  • Chad A Hudson
  • Angelika Zaremba
  • Michael Panos
  • Robert J Homer
  • Andreas Faissner

Detail Information

Publications86

  1. ncbi Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice
    V Lipsanen
    Department of Pathobiology, University of Guelph, Ontario, Canada
    Int Immunol 9:655-64. 1997
    ..autoantibodies (AAb), we compared the genetic and structural characteristics of IgM AAb from autoimmune prone motheaten (mev) mice with natural autoantibodies (NAAb) from normal background C57/BL6 strain...
  2. ncbi The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate
    K L Berg
    Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA
    Oncogene 17:2535-41. 1998
    ..a substrate of SHP-1 in vitro and is hyperphosphorylated on tyrosine in SHP-1 deficient macrophages from viable-motheaten mice...
  3. ncbi The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells
    J Zhang
    Department of Immunology, University of Toronto, The Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Ontario, Canada
    J Immunol 162:6359-67. 1999
    ..of SHP-1 on TCR-mediated apoptosis by assaying the sensitivity of peripheral T cells from SHP-1-deficient viable motheaten (mev) mice to cell death following TCR restimulation...
  4. ncbi Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice
    Melissa J Joliat
    The Jackson Laboratory, Bar Harbor, ME 04609, USA
    J Autoimmun 18:105-17. 2002
    Mice homozygous for the viable motheaten (Hcph(me-v)) mutation are deficient in SHP-1 protein-tyrosine phosphatase, resulting in severe systemic autoimmunity and immune dysfunction...
  5. ncbi SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC
    Anita M Kant
    Herman B Wells Center for Pediatrics Research, Indiana University School of Medicine, Indianapolis 46202, USA
    Blood 100:1852-9. 2002
    ....
  6. ncbi Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13
    T L Yi
    Department of Biochemistry, St Jude Children s Research Hospital, Memphis, Tennessee 38105
    Mol Cell Biol 12:836-46. 1992
    ..Importantly, the human gene maps to chromosome 12 region p12-p13. This region is associated with rearrangements in approximately 10% of cases of acute lymphocytic leukemia in children...
  7. ncbi The interaction of the xid and me genes
    C L Scribner
    J Immunol 138:3611-7. 1987
    The murine "motheaten" (me) mutation has been bred onto the NFS background and combined with the X-linked immunodeficiency (xid) mutation to investigate the effect of the xid-induced B cell maturational block on the widespread ..
  8. ncbi High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages
    A Veillette
    McGill Cancer Centre, McGill University, Montreal, Quebec, Canada H3G 1Y6
    J Biol Chem 273:22719-28. 1998
    ..Taken together, these findings indicate that SHPS-1 is likely to play a significant role in macrophages, at least partially as a consequence of its capacity to recruit SHP-1...
  9. ncbi Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1
    R F Paulson
    Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
    Nat Genet 13:309-15. 1996
    ..murine Dominant white spotting (W) locus and the Shp1 protein tyrosine phosphatase, the product of the murine motheaten (me) gene...
  10. ncbi Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
    L D Shultz
    Jackson Laboratory, Bar Harbor, Maine 04609
    Cell 73:1445-54. 1993
    Mice homozygous for the recessive allelic mutation motheaten (me) or viable motheaten (mev) on chromosome 6 develop severe defects in hematopoiesis...
  11. ncbi Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency
    L D Shultz
    Jackson Laboratory, Bar Harbor, ME 04609, USA
    Trends Biotechnol 15:302-7. 1997
    ..Mutations at the 'motheaten' locus result in severe immunological dysfunction due to disruption of the structural gene encoding Src-homology ..
  12. ncbi Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection
    J G Cyster
    Department of Microbiology and Immunology, Beckman Center, Stanford University School of Medicine, California 94305, USA
    Immunity 2:13-24. 1995
    b>Motheaten viable (mev) mice are deficient in the cytosolic protein tyrosine phosphatase, PTP1C, and exhibit severe B cell immunodeficiency and autoantibody production...
  13. ncbi Lack of the protein tyrosine phosphatase SHP-1 results in decreased numbers of glia within the motheaten (me/me) mouse brain
    C A Wishcamper
    Department of Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, USA
    J Comp Neurol 441:118-33. 2001
    Mice that are homozygous for the autosomal recessive motheaten allele (me/me) lack the protein tyrosine phosphatase SHP-1...
  14. ncbi Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences
    R J Matthews
    Howard Hughes Medical Institute, Washington University School of Medicine, St Louis, Missouri 63110
    Mol Cell Biol 12:2396-405. 1992
    ..These two additional members of the PTPase family accentuate the variety of PTPase structures and indicate the potential diversity of function for intracellular tyrosine phosphatases...
  15. ncbi Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
    H W Tsui
    Toronto Hospital, Ontario, Canada
    Nat Genet 4:124-9. 1993
    Mice with the recessive motheaten (me) or the allelic viable motheaten (mev) mutations express a severe autoimmune and immunodeficiency syndrome...
  16. ncbi B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity
    Lily I Pao
    Cancer Biology Program, Division of Hematology Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
    Immunity 27:35-48. 2007
    Spontaneous loss-of-function mutations in the protein-tyrosine phosphatase Shp1 cause the motheaten phenotype, characterized by widespread inflammation and autoimmunity...
  17. ncbi Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1
    U Lorenz
    Molecular Medicine Unit, Beth Israel Hospital, Boston, Massachusetts, USA
    J Exp Med 184:1111-26. 1996
    ..between the RTK c-Kit, encoded at the W locus, and the SH2-containing non-transmembrane PTP SHP1, encoded at the motheaten (me) locus (1)...
  18. ncbi Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice
    M Kozlowski
    Department of Medicine, University of Toronto, Ontario, Canada
    J Exp Med 178:2157-63. 1993
    ..containing a COOH-terminal catalytic and two NH2-terminal Src homology 2 (SH2) domains, have been identified in motheaten (me) and viable motheaten (mev) mice and are associated with severe hemopoietic dysregulation...
  19. ncbi A novel role for protein tyrosine phosphatase shp1 in controlling glial activation in the normal and injured nervous system
    A Horvat
    Department of Neuromorphology, Max Planck Institute of Neurobiology, D 82152 Martinsried, Germany
    J Neurosci 21:865-74. 2001
    ..These results emphasize that SHP1 as a part of different signaling pathways plays an important role in the global regulation of astrocytic and microglial activation in the normal and injured CNS...
  20. ncbi "Viable motheaten," a new allele at the motheaten locus. I. Pathology
    L D Shultz
    Am J Pathol 116:179-92. 1984
    A new spontaneous autosomal recessive mutation has recently occurred at the motheaten (me) locus on Chromosome 6 in strain C57BL/6J mice...
  21. ncbi Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes
    W F Davidson
    J Immunol 122:884-91. 1979
    ..It remains to be determined what the basic deficiency in me/me mice is and whether it affects primarily B cells or all lymphoid cells...
  22. ncbi Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density
    S Umeda
    Jackson Laboratory, Bar Harbor, Maine Kumamoto University of Medicine, Kumamoto, Japan
    Am J Pathol 155:223-33. 1999
    Mice homozygous for the motheaten (Hcphme) or viable motheaten (Hcphme-v) mutations are deficient in functional SHP-1 protein-tyrosine phosphatase and show severe defects in hematopoiesis...
  23. ncbi Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice
    Paul T Massa
    Department of Neurology, Neuroscience Program, SUNY Upstate Medical University, Syracuse, New York 13066, USA
    J Neurosci Res 77:15-25. 2004
    ..express the protein tyrosine phosphatase SHP-1 and that myelin formation was decreased in SHP-1-deficient motheaten mice compared to that in normal littermates...
  24. ncbi Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology
    M C Green
    J Hered 66:250-8. 1975
    A new recessive mutation, motheaten (me), is on chromosome 6, 21.9 +/- 4.3 recombination units distal to white (Miwh)...
  25. ncbi Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice
    Shin ichi Hayashi
    Division of Immunology, Department of Molecular and Cellular Biology, School of Life Science, Faculty of Medicine, Tottori University, 86 Nishi Machi, Yonago, Tottori 683 8503, Japan
    Endocrinology 145:2721-9. 2004
    ..mature osteoclasts were generated from protein tyrosine phosphatase Src homology 2-domain phosphatase-1-defective Hcph(me-v)/Hcph(me-v) (me(v)/me(v)) bone marrow cells in the presence of M-CSF and LPS without addition of RANKL in ..
  26. ncbi Cochlear ablation in mice lacking SHP-1 results in an extended period of cell death of anteroventral cochlear nucleus neurons
    Jie Zhao
    Department of Biomedical and Pharmaceutical Sciences, School of Pharmacy and Allied Health Sciences, University of Montana, Missoula, 59812, USA
    Hear Res 189:63-75. 2004
    ..These results indicate that activated microglia may participate in determining whether neurons in AVCN live or die following deafferentation...
  27. ncbi Dynamic changes in the expression of protein tyrosine phosphatases during preimplantation mouse development: semi-quantification by real-time PCR
    Kentaro T Hara
    Graduate School of Frontier Sciences, University of Tokyo, Shinryoiki Seimei Building 302, Kashiwa, Chiba 277 8562, Japan
    J Reprod Dev 49:323-8. 2003
    ..This suggests that PTPs are involved in the regulation of growth and differentiation during preimplantation development...
  28. ncbi CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation
    Dong Hui Chung
    Veterans Administration Medical Center and University of California, San Francisco, CA 94121, USA
    J Immunol 171:6541-8. 2003
    ..Thus, we define a new family of myeloid receptors, and demonstrate that the first member of this family, CLM-1, is an inhibitory receptor, able to block osteoclastogenesis...
  29. ncbi Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling
    Nicholas R D Paling
    Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK
    Biochem J 368:885-94. 2002
    ..These results demonstrate that SHP-1 acts to negatively regulate IL-3-driven survival and proliferation, potentially via regulation of tyrosine phosphorylation of Aic2A and STAT5...
  30. ncbi Visualization of SHP-1-target interaction
    Christoph Biskup
    Institute of Physiology II, Medical Faculty, Friedrich Schiller University, Drackendorfer Str 1, 07747 Jena, Germany
    J Cell Sci 117:5165-78. 2004
    ....
  31. ncbi TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1
    Il Kyoo Park
    Department of Pathology, Dartmouth Medical School, Lebanon, NH 03756, USA
    J Immunol 175:5666-74. 2005
    ..Together, these data show that TGF-beta1 suppresses IFN-gamma signaling and transcriptional responses in CD4+ T cells through the PTP Shp-1...
  32. ncbi Lactation defect in a widely used MMTV-Cre transgenic line of mice
    Taichang Yuan
    Department of Pathology, University of Colorado School of Medicine, University of Colorado, Aurora, Colorado, United States of America
    PLoS ONE 6:e19233. 2011
    ..Here, we describe a lactation defect that severely limits the use of one of the most commonly used MMTV-Cre founder lines...
  33. ncbi SHP-1 deficient mast cells are hyperresponsive to stimulation and critical in initiating allergic inflammation in the lung
    Li Zhang
    Division of Allergy and Clinical Immunology, The Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA
    J Immunol 184:1180-90. 2010
    ..survival, and functional responses to stimulation using bone marrow-derived mast cells from viable motheaten (mev) mice...
  34. ncbi Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity
    Alexander Nyström
    Department of Pathology, Anatomy, and Cell Biology, and Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, 1020 Locust Street, Philadelphia, PA 19107, USA
    Blood 114:4897-906. 2009
    ..Our results show that SHP-1 is an essential mediator of endorepellin activity and discover a novel functional interaction between the integrin alpha2 subunit and SHP-1...
  35. ncbi Protein tyrosine phosphatases expression during development of mouse superior colliculus
    Jacqueline Reinhard
    Department of Cell Morphology and Molecular Neurobiology, Faculty of Biology, Ruhr University Bochum, Universitaetsstr 150, 44780, Bochum, Germany
    Exp Brain Res 199:279-97. 2009
    ..Subsequently, the expression patterns of 11 PTPs (TC-PTP, PTP1C, PTP1D, PTP-MEG2, PTP-PEST, RPTPJ, RPTPε, RPTPRR, RPTPσ, RPTPκ and RPTPγ) were further analyzed in detail in ..
  36. ncbi Hippocampal SH2-containing protein-tyrosine phosphatases are involved in extinction of contextual fear
    Tomoko Isosaka
    Department of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
    Neuroreport 21:554-8. 2010
    ..These findings suggest that SHP1/2 activity in the hippocampus is involved in the control of contextual fear extinction...
  37. ncbi Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5
    Wenbin Xiao
    Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA
    Cancer Cell 16:161-71. 2009
    ..The same mechanism for malignant transformation seems to be operative in other human lymphoid and myeloid malignancies. Thus, PLC-beta3 is likely a tumor suppressor...
  38. ncbi The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo
    Hyun Ju Kim
    Department of Pathology and Immunology, Washington University, St Louis, MO 63110, USA
    Proc Natl Acad Sci U S A 106:2325-30. 2009
    ..The most pragmatic aspect of our findings is that successful therapeutic inhibition of c-Src, in the context of the osteoclast, will require its stringent targeting...
  39. ncbi Positive and negative regulation of high affinity IgE receptor signaling by Src homology region 2 domain-containing phosphatase 1
    Kazuko Nakata
    Department of Immunology and Signal Transduction, Tokyo Metropolitan Institute for Neuroscience, Tokyo Metropolitan Organization for Medical Science, Fuchu, Tokyo, Japan
    J Immunol 181:5414-24. 2008
    ..how SHP-1 regulates mast cell signaling, we established bone marrow-derived mast cells from SHP-1-deficient motheaten and wild-type mice and analyzed downstream signals induced by cross-linking of high affinity IgE receptor, Fc ..
  40. ncbi Loss of Src homology region 2 domain-containing protein tyrosine phosphatase-1 increases CD8+ T cell-APC conjugate formation and is associated with enhanced in vivo CTL function
    Jean G Sathish
    Section of Infection and Immunity, Department of Medical Biochemistry and Immunology, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom
    J Immunol 178:330-7. 2007
    ..Specifically, T cells from the SHP-1-deficient mouse, motheaten, exhibit a hyperproliferative phenotype when activated by cognate peptide-pulsed APCs...
  41. ncbi The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis
    Marie Julie Dubois
    Department of Anatomy Physiology and Lipid Research Unit, Laval University Hospital Research Center, 2705 Laurier Boulevard, Quebec, Quebec G1V 4G2, Canada
    Nat Med 12:549-56. 2006
    ..Here we show that Ptpn6(me-v/me-v) (also known as viable motheaten) mice bearing a functionally deficient SHP-1 protein are markedly glucose tolerant and insulin sensitive as ..
  42. ncbi Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia
    Celine A Beamer
    Center for Environmental Health Sciences, School of Pharmacy and Allied Health Sciences, University of Montana, Missoula 59812 1552, USA
    J Neurosci Res 83:1220-30. 2006
    ....
  43. ncbi Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration
    Bonnie L Lyons
    The Jackson Laboratory, Bar Harbor, Maine 04609, USA
    Invest Ophthalmol Vis Sci 47:1201-9. 2006
    Viable motheaten mutant mice (abbreviated allele symbol me(v)) are deficient in Src-homology 2-domain phosphatase (SHP)-1, a critical negative regulator of signal transduction in hematopoietic cells...
  44. ncbi Activation of Cdk2 stimulates proteasome-dependent truncation of tyrosine phosphatase SHP-1 in human proliferating intestinal epithelial cells
    Mélanie Simoneau
    Département d Anatomie et Biologie Cellulaire, Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
    J Biol Chem 283:25544-56. 2008
    ..In conclusion, our results indicate that Cdk2-associated complexes, by targeting SHP-1 for proteolysis, counteract the ability of SHP-1 to block cell cycle progression of IECs...
  45. ncbi The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells
    Tessy Iype
    Beirne B Carter Center for Immunology Research, Department of Microbiology, University of Virginia, Charlottesville, VA 22908, USA
    J Immunol 185:6115-27. 2010
    ..Collectively, our data reveal SHP-1 as a critical modifier of Treg function and a potential therapeutic target for augmenting Treg-mediated suppression in certain disease states...
  46. ncbi Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1
    B Lowin-Kropf
    Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland
    J Immunol 165:1314-21. 2000
    ..A similar NK cell phenotype is observed in viable motheaten (mev) mice, which show reduced SHP-1 activity due to a mutation in the Shp-1 gene...
  47. ncbi Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection
    J Zhang
    Department of Immunology, University of Toronto, The Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
    J Immunol 163:3012-21. 1999
    ..analysis of T cell development in H-Y TCR transgenic mice rendered SHP-1 deficient by introduction of the viable motheaten mutation or a dominant negative SHP-1-encoding transgene...
  48. ncbi Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev)
    G Van Zant
    Department of Cell Biology and Anatomy, Texas Tech University Health Sciences Center, Lubbock 79430
    Exp Hematol 17:81-7. 1989
    We have studied the hematopoietic system of the immunodeficient mouse mutant, viable motheaten (mev/mev). These mice usually die by 9 weeks of age from severe pneumonitis...
  49. ncbi Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis
    Caishu Deng
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 9036, USA
    J Neuroimmunol 138:76-82. 2003
    ....
  50. ncbi The viable motheaten (mev) mouse--a new model for arthritis
    J Kovarik
    Immunology Department, Sandoz Pharma Ltd, Basel, Switzerland
    J Autoimmun 7:575-88. 1994
    ..These results indicate the particular sensitivity of this model for efficacy of potentially new therapeutic but non-cytostatic compounds for clinical use...
  51. ncbi Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6
    M A Ansari-Lari
    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA
    Genome Res 8:29-40. 1998
    ....
  52. ncbi SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses
    W Yang
    Department of Cancer Biology, The Lerner Research Institute of The Cleveland Clinic Foundation, Cleveland, OH, USA
    Blood 91:3746-55. 1998
    ..as demonstrated by the heightened growth responses to hematopoietic growth factors in hematopoietic cells of motheaten mice, which lack functional SHP-1 expression due to mutations in the SHP-1 gene...
  53. ncbi Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase
    K Nakayama
    Second Department of Pathology, Kumamoto University School of Medicine, Japan
    Int J Exp Pathol 78:245-57. 1997
    In mice homozygous for the 'viable motheaten' (mev) mutation, numbers of macrophage progenitor cells, particularly monocytes, were markedly increased in the bone marrow and spleen...
  54. ncbi Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction
    H Jiao
    Department of Cancer Biology, Cleveland Clinic Research Institute, OH 44195, USA
    Exp Hematol 25:592-600. 1997
    ..cell phosphatase (HCP) underlies severe hematopoietic and immunologic abnormalities in mice homozygous for the motheaten and viable motheaten mutations...
  55. ncbi Hematopoietic cell protein-tyrosine phosphatase-deficient motheaten mice exhibit T cell apoptosis defect
    X Su
    Department of Medicine, The University of Alabama at Birmingham, AL 35294, USA
    J Immunol 156:4198-208. 1996
    ..on the T cell phenotype and apoptosis function in hematopoietic cell protein-tyrosine phosphatase-deficient motheaten mice...
  56. ncbi Genetic analysis of B cell antigen receptor signaling
    T Kurosaki
    Department of Molecular Genetics, Kansai Medical University, Moriguchi, Japan
    Annu Rev Immunol 17:555-92. 1999
    ....
  57. ncbi Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins
    L D Shultz
    J Immunol 116:936-43. 1976
    Mice homozygous for the recessive mutation motheaten (me) are deficient in capacity for immune response but show an elevated level of serum immunoglobulins...
  58. ncbi SHP-1 variant proteins are absent in motheaten mice despite presence of splice variant transcripts with open reading frames
    A Martin
    Department of Immunology, University of Toronto, Ontario, Canada
    Mol Immunol 36:1029-41. 1999
    b>Motheaten mice have a mutation that causes abnormal splicing of the SHP-1 gene producing transcripts that are out of frame. Thus, motheaten mice cannot produce normal SHP-1 protein...
  59. ncbi Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6
    T Yi
    Department of Biochemistry, St Jude Children s Research Hospital, Memphis, Tennessee 38105
    Genomics 14:793-5. 1992
    Hematopoietic cell phosphatase (Hcph) was identified by amplification of conserved protein tyrosine phosphatase sequences from a myeloid cell line and is predominantly expressed in hematopoietic cells...
  60. ncbi The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice
    K Aoki
    Department of Orthopaedics, and Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06510, USA
    Bone 25:261-7. 1999
    ..mutations of the Src homology 2 (SH2) domain-containing tyrosine phosphatase 1 (SHP-1) in mice give rise to the motheaten (me) phenotype...
  61. ncbi Effect of genetically determined immunodeficiency on epidermal dendritic cell populations in C57BL/6J mice
    E Sprecher
    Department of Molecular Virology, Faculty of Medicine, Hebrew University, Jerusalem, Israel
    Arch Dermatol Res 282:188-93. 1990
    ..were determined using indirect immunofluorescence microscopy of epidermal whole mounts taken from viable motheaten (mev), nude (nu), and rhino (rhhr) mice...
  62. ncbi Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses
    C H Kim
    Department of Microbiology Immunology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    J Exp Med 190:681-90. 1999
    ..activities induced by chemokines, we examined the role of SHP-1 in functions of chemokines using viable motheaten (me(v)/me(v)) mice that were deficient in SHP-1...
  63. ncbi Mutations in mice that influence natural killer (NK) cell activity
    E A Clark
    Immunogenetics 12:601-13. 1981
    ..loci that reduce NK-cell activity in the homozygous state were identified, including beige (bg), hairless (hr), motheaten (me), obese (ob), steel (Sl) and, to lesser extent, dominant spotting (W)...
  64. ncbi Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases
    Hiroyuki Nishimura
    Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138
    Proc Natl Acad Sci U S A 103:3292-7. 2006
    ....
  65. ncbi Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease
    George P Christophi
    Department of Neurology, SUNY Upstate Medical University, Syracuse, New York 13210, USA
    J Virol 83:522-39. 2009
    ....
  66. ncbi The mouse mutant "motheaten." II. Functional studies of the immune system
    C L Sidman
    J Immunol 121:2399-404. 1978
    b>Motheaten mice have normal levels of T lymphocytes but reduced levels of B lymphocytes...
  67. ncbi Localization of prothymocytes from wild-type and viable motheaten mice following intravenous injection into irradiated adoptive recipients
    S M Hayes
    Department of Pathology, University of Connecticut Health Center, Farmington 06030
    Cell Immunol 153:344-55. 1994
    Bone marrow cells from viable motheaten (me(v)) mutant mice fail to repopulate the thymus of irradiated recipients upon i.v. adoptive transfer...
  68. ncbi A serum-derived molecule from autoimmune viable motheaten mice potentiates the action of a B cell maturation factor
    C L Sidman
    J Immunol 135:870-2. 1985
  69. ncbi Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice
    Sihoon Lee
    Diabetes Unit, National Center for Complementary and Alternative Medicine, National Institutes of Health, 9 Memorial Drive, Bethesda, MD 20892 0920, USA
    Am J Physiol Endocrinol Metab 294:E261-70. 2008
    ..This may reflect intrinsic differences between human and rodent physiology as well as increased technical difficulties in performing glucose clamps in mice...
  70. ncbi Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II
    Bitao Liang
    Departments of Microbiology, Pharmacology and Medicine, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA
    J Immunol 180:5916-26. 2008
    ..These data reveal a novel ITAM-mediated inhibitory signaling pathway in DCs triggered by MHC II engagement of LAG-3, providing a molecular mechanism in which regulatory T cells may suppress via modulating DC function...
  71. ncbi A critical role of SHP-1 in regulation of type 2 inflammation in the lung
    Sun Young Oh
    Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Am J Respir Cell Mol Biol 40:568-74. 2009
    ..we sought to define the function of SHP-1 in the lung by characterizing the pulmonary inflammation of viable motheaten (mev) mice, and to investigate the molecular mechanisms involved...
  72. ncbi Aberrant regulation of bone trace elements in motheaten and osteopetrosis mutant mice
    G Yamada
    Research Center for Innovative Cancer Therapy, Kurume University, Fukuoka, Japan
    Cell Mol Biol (Noisy-le-grand) 44:315-9. 1998
    ..In this paper, two murine mutant mice viable motheaten and osteopetrosis are analyzed...
  73. ncbi Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner
    Yoon Kwang Lee
    Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Biol Chem 277:2463-7. 2002
    ..We conclude that the proposed central role of SHP in cholesterol metabolism is based on a two-step mechanism that is dependent on both coactivator competition and direct transcriptional repression...
  74. ncbi Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis
    G Forget
    Centre de Recherche en Infectiologie CHUQ, Universite Laval, Ste Foy, Quebec, Canada
    Eur J Immunol 31:3185-96. 2001
    ..In vivo, Leishmania major infection, which footpad inflammation is mostly undetectable in SHP-1-deficient viable motheaten mice, was accompanied by increased inducible nitric oxide synthase and activation of neutrophils...
  75. ncbi Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function: studies in motheaten mice
    J Kruger
    Division of Respirology, The Toronto General Hospital Research Institute of the University Health Network, Toronto, Ontario, Canada
    J Immunol 165:5847-59. 2000
    ..however, implied by the overexpansion and inappropriate activation of granulocyte populations in SHP-1-deficient motheaten (me/me) and motheaten viable (me(v)/me(v)) mice...
  76. ncbi Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis
    Caishu Deng
    Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    J Immunol 168:4511-8. 2002
    ..These data demonstrate that the level of SHP-1 plays an important role in regulating the activation threshold of autoreactive T cells...
  77. ncbi Characterization of a novel receptor that maps near the natural killer gene complex: demonstration of carbohydrate binding and expression in hematopoietic cells
    M J Fernandes
    Thomas Jefferson University, Department of Microbiology and Immunology, Kimmel Cancer Institute, Philadelphia, Pennsylvania 19107, USA
    Cancer Res 59:2709-17. 1999
    ..Moreover, its expression is not restricted to natural killer cells, as reported for the majority of group V lectins. Nkcl is expressed in pluripotent myeloid precursors, precursor and mature macrophages, and neutrophils...
  78. ncbi SHP-1 deficiency in B-lineage cells is associated with heightened lyn protein expression and increased lyn kinase activity
    W Yang
    Department of Cancer Biology, The Lerner Research Institute, Cleveland Clinic Foundation, Ohio 44195, USA
    Exp Hematol 26:1126-32. 1998
    ..In the present study, we derived two pre-B cell lines, PBCL-1 and PBCL-2, from normal and SHP-1-deficient motheaten mice, respectively, and characterized hyperphosphorylated proteins in PBCL-2 cells to identify SHP-1-regulated ..
  79. ncbi Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells
    Hidetoshi Kumagai
    Division of Hematopoietic Factors, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, 6 1 Shirokanedai 4 chome, Minato ku, Tokyo 108 8639, Japan
    Biochem Biophys Res Commun 307:719-29. 2003
    ..These findings suggest that a new pair of ITIM/ITAM-bearing receptors, LMIR1 and 2, regulate mast cell-mediated inflammatory responses through yet to be defined ligand(s)...
  80. ncbi Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis
    Zhiyuan Zhang
    Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA
    J Immunol 171:3620-6. 2003
    ..Therefore, SHP-1 plays a role in signals downstream of RANKL by recruitment to the complex containing TRAF6 and these observations may help to understand the mechanism of osteoporosis in Me(v)/Me(v) mice...
  81. ncbi IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor
    Zan Huang
    Graduate Program in Molecular Biology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA
    J Immunol 174:1332-7. 2005
    ..mutation did not affect IL-4-induced STAT6 phosphorylation in differentiated Th1 cells derived from viable motheaten (me(v)/me(v)) mice. These results led us to focus on a novel mechanism...
  82. ncbi The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages
    T I Roach
    Department of Pathology, Howard Hughes Medical Institute, Washington University School of Medicine, St Louis, Missouri 63130, USA
    Curr Biol 8:1035-8. 1998
    ..The viable motheaten (Hcphme-v) mutant mice (mev) suffer from progressive inflammation due to a deficiency of SHP-1 enzyme activity [..
  83. ncbi Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model
    Guo Wei
    Department of Molecular Genetics, Ohio State University, Columbus, OH 43210, USA
    J Immunol 173:1374-9. 2004
    ..Thr(72) in macrophages derived from mice homozygous for the motheaten viable (me-v) allele of the hemopoietic cell phosphatase (Hcph) gene...
  84. ncbi Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1
    Y G Yeung
    Department of Developmental Biology and Cancer, Albert Einstein College of Medicine, Bronx, New York 10461
    J Biol Chem 267:23447-50. 1992
    ..The rapid, growth factor-induced tyrosine phosphorylation of PTP-1C suggests that it may be involved in very early events in growth factor signal transduction...
  85. ncbi CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation
    Fabiano Pinheiro da Silva
    Institut National de la Santé et de la Recherche Médicale U699, 16 rue Henri Huchard, Paris F 75018, France
    Nat Med 13:1368-74. 2007
    ..coli phagocytosis. Thus, by binding FcgammaRIII, E. coli triggers an inhibitory FcRgamma pathway that both impairs MARCO-mediated bacterial clearance and activates TNF-alpha secretion...
  86. ncbi Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases
    M Nakamuta
    Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Biol Chem 270:13042-56. 1995
    ..e. upstream of exon 1) have predominantly hepatic promoter activity and the 5'-flanking sequences of the major small intestine mRNA (i.e. upstream of exon 4) have preferential intestinal promoter activity.(ABSTRACT TRUNCATED AT 400 WORDS)..

Research Grants30

  1. Genes that Mediate Tolerance to the Placental Allograft
    Bruce Beutler; Fiscal Year: 2006
    ..Fourth, circumvention of the toleragenic mechanism might be used to prevent normal gestation, leading to termination of pregnancy within a few days following implantation of the blastocyst. ..
  2. A Critical Role for SHP-1 in Retinal Degeneration
    Bonnie Lyons; Fiscal Year: 2006
    ..The viable motheaten mutation results in severe SHP- 1 deficiency and provides a critical tool for elucidating the mechanism of ..
  3. Forward Genetic Analysis of the Innate Immune Contribution to MCMV Resistance
    Bruce Beutler; Fiscal Year: 2006
    ..Because it is clear that innate immunity is degenerate in that individual proteins frequently offer broad defense against bacterial, viral, and fungal pathogens, these studies will yield insight into innate immune mechanisms at large. ..
  4. Mutagenic analysis of LPS responses
    Bruce Beutler; Fiscal Year: 2006
    ..In the case of mutations that abolish LPS tolerance, we will attempt to determine the net impact on host resistance to infection. ..
  5. TLR4 as an LPS sendor and susceptibility locus
    Bruce Beutler; Fiscal Year: 2007
    ..The new mutations that are found--and those that have already been found in preliminary efforts--will be isolated by positional cloning. ..
  6. REGULATION OF INTERFERON ACTIVITY BY SHP-1 IN THE CNS
    PAUL MASSA; Fiscal Year: 2007
    ..We believe that information gained under these specific aims will elucidate mechanisms whereby SHP-1 controls virus infections in oligodendrocytes and perhaps other cells of the CNS. ..
  7. Mutagenetic analysis of LPS responses
    Bruce Beutler; Fiscal Year: 2007
    ..This work will enrich our understanding of how and why infections are sometimes lethal. ..
  8. Deficiency of SHP-1 expression and function in multiple sclerosis
    Paul T Massa; Fiscal Year: 2010
    ..abstract_text> ..
  9. TLR4 AS AN LPS SENSOR AND SUSCEPTIBILITY LOCUS
    Bruce Beutler; Fiscal Year: 2003
    ..Lps/n, the common wild-type Lps allele; Tlr4/Lps-d, the Lps/d allele of Tlr4; Tlr4/Lps-n, the Lps/n allele of Tlr4. ..
  10. REGULATION OF INTERFERON ACTIVITY BY SHP-1 IN THE CNS
    PAUL MASSA; Fiscal Year: 2003
    ..Mice genetically deficient in SHP- I (motheaten and viable motheaten mice) have a dramatically increased susceptibility to the attenuated BeAn strain of Theiler'..
  11. Role of SHP-1 in monocyte-mediated demyelination
    Paul T Massa; Fiscal Year: 2010
    ..The present project is thus focused on defining the essential role of SHP-1 in macrophage-mediated demyelinating disease. ..